Cancer Interactome Overview
It is well appreciated that cancer is a complex disease accounted for by cellular dysfunction. It is further well appreciated that the multiple molecular pathways involved in the hundreds of conditions collectively called cancer are at the heart of this complexity. The ability to explore and understand the interaction of nucleic acids and proteins will be critical for offering patients improved diagnosis and treatment for their conditions. In order to achieve this, an integration of various molecular profiling technologies (e.g. genomic, proteomic, metabolomics, etc) and the data management and processing tools that will facilitate this will be required. The IMAT and ITCR programs support a variety of technology development projects likely to contribute to this potential. This project site is intended to facilitate broad awareness of relevant projects and catalyze collaborations between complementary groups.